Page 136 - 2020_07-Haematologica-web

I. Truxova et al.
decrease in heat shock protein 70 mem-
brane-positive tumor cells is associated with reduced sensitivity to natural killer cell lysis, growth delay, and altered growth morpholo- gy. Cell Stress Chaperones. 2005;10(2):136- 146.
16. Gross C, Holler E, Stangl S, et al. An Hsp70 peptide initiates NK cell killing of leukemic blasts after stem cell transplantation. Leuk Res. 2008;32(4):527-534.
17. Multhoff G, Pfister K, Botzler C, et al. Adoptive transfer of human natural killer cells in mice with severe combined immun- odeficiency inhibits growth of Hsp70- expressing tumors. Int J Cancer. 2000; 88(5):791-797.
18. Gastpar R, Gehrmann M, Bausero MA, et al. Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res. 2005;65(12):5238-5247.
19. Vulpis E, Cecere F, Molfetta R, et al. Genotoxic stress modulates the release of exosomes from multiple myeloma cells capable of activating NK cell cytokine pro- duction: Role of HSP70/TLR2/NF-kB axis. Oncoimmunology. 2017;6(3):e1279372.
20. Qiu Y, Yang J, Wang W, et al. HMGB1-pro- moted and TLR2/4-dependent NK cell matu- ration and activation take part in rotavirus- induced murine biliary atresia. PLoS Pathog. 2014;10(3):e1004011.
21. Panaretakis T, Kepp O, Brockmeier U,
Tesniere A, Bjorklund AC, Chapman DC, et al. Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. EMBO J. 2009;28(5):578-590.
22. Zingoni A, Fionda C, Borrelli C, Cippitelli M, Santoni A, Soriani A. Natural killer cell response to shemotherapy-stressed cancer cells: role in tumor immunosurveillance. Front Immunol. 2017; 8:1194.
23. Degli-Esposti MA, Smyth MJ. Close encoun- ters of different kinds: dendritic cells and NK cells take centre stage. Nat Rev Immunol. 2005;5(2):112-124.
24. Van den Bergh JM, Lion E, Van Tendeloo VF, Smits EL. IL-15 receptor alpha as the magic wand to boost the success of IL-15 antitumor therapies: The upswing of IL-15 transpresen- tation. Pharmacol Ther. 2017;170:73-79.
25. Costello RT, Fauriat C, Sivori S, Marcenaro E, Olive D. NK cells: innate immunity against hematological malignancies? Trends Immunol. 2004;25(6):328-333.
26. Delahaye NF, Rusakiewicz S, Martins I, et al. Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors. Nat Med. 2011;17(6):700-707.
27. Khaznadar Z, Boissel N, Agaugue S, et al. Defective NK Cells in Acute myeloid leukemia patients at diagnosis are associated with blast transcriptional signatures of immune evasion. J Immunol. 2015;195(6): 2580-2590.
28. Kroemer G, Senovilla L, Galluzzi L, Andre F,
Zitvogel L. Natural and therapy-induced immunosurveillance in breast cancer. Nat Med. 2015;21(10):1128-1138.
29. Pasero C, Gravis G, Granjeaud S, et al. Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer. Oncotarget. 2015;6(16): 14360-14373.
30. Galluzzi L, Yamazaki T, Kroemer G. Linking cellular stress responses to systemic home- ostasis. Nat Rev Mol Cell Biol. 2018;19 (11):731-745.
31. Fuertes MB, Woo SR, Burnett B, Fu YX, Gajewski TF. Type I interferon response and innate immune sensing of cancer. Trends Immunol. 2013;34(2):67-73.
32. Mattei F, Schiavoni G, Belardelli F, Tough DF. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J Immunol. 2001; 167(3):1179-1187.
33. Chen X, Fosco D, Kline DE, Kline J. Calreticulin promotes immunity and type I interferon-dependent survival in mice with acute myeloid leukemia. Oncoimmunology. 2017;6(4):e1278332.
34. Han B, Mao FY, Zhao YL, et al. Altered NKp30, NKp46, NKG2D, and DNAM-1 expression on circulating NK cells is associ- ated with tumor progression in human gastric cancer. J Immunol Res. 2018;2018: 6248590.
1878
haematologica | 2020; 105(7)